{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3-chymotrypsin-like cysteine protease", "SARS-CoV-2", "coronavirus disease 2019", "main protease", "plant products", "plant-derived 3CLpro inhibitors"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33767619", "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "09"}], "Language": ["eng"], "ELocationID": ["583387", "10.3389/fphar.2021.583387"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Plant Products as Inhibitors of Coronavirus 3CL Protease.", "Pagination": {"StartPage": "583387", "MedlinePgn": "583387"}, "Abstract": {"AbstractText": ["<b>Background:</b> The ongoing COVID-19 pandemic has created an alarming situation due to extensive loss of human lives and economy, posing enormous threat to global health security. Till date, no antiviral drug or vaccine against SARS-CoV-2 has reached the market, although a number of clinical trials are under way. The viral 3-chymotrypsin-like cysteine protease (3CL<sup>pro</sup>), playing pivotal roles in coronavirus replication and polyprotein processing, is essential for its life cycle. In fact, 3CL<sup>pro</sup> is already a proven drug discovery target for SARS- and MERS-CoVs. This underlines the importance of 3CL protease in the design of potent drugs against COVID-19. <b>Methods:</b> We have collected one hundred twenty-seven relevant literatures to prepare the review article. PubMed, Google Scholar and other scientific search engines were used to collect the literature based on keywords, like \"SARS-CoVs-3CL protease,\" \"medicinal plant and anti-SARS-CoVs-3CL protease\" published during 2003-2020. However, earlier publications related to this topic are also cited for necessary illustration and discussion. Repetitive articles and non-English studies were excluded. <b>Results:</b> From the literature search, we have enlisted medicinal plants reported to inhibit coronavirus 3CL protease. Some of the plants like <i>Isatis tinctoria</i> L. (syn. <i>Isatis indigotica</i> Fort.)<i>, Torreya nucifera</i> (L.) Siebold and Zucc., <i>Psoralea corylifolia</i> L., and <i>Rheum palmatum</i> L. have exhibited strong anti-3CL<sup>pro</sup> activity. We have also discussed about the phytochemicals with encouraging antiviral activity, such as, bavachinin, psoralidin, betulinic acid, curcumin and hinokinin, isolated from traditional medicinal plants. <b>Conclusion:</b> Currently, searching for a plant-derived novel drug with better therapeutic index is highly desirable due to lack of specific treatment for SARS-CoV-2. It is expected that in-depth evaluation of medicinally important plants would reveal new molecules with significant potential to inhibit coronavirus 3CL protease for development into approved antiviral drug against COVID-19 in future."], "CopyrightInformation": "Copyright \u00a9 2021 Mandal, Jha and Hazra."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Mrinalini Datta Mahavidyapith, Kolkata, India."}], "LastName": "Mandal", "ForeName": "Anirban", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Animal Health Research Division, Nepal Agricultural Research Council, Kathmandu, Nepal."}], "LastName": "Jha", "ForeName": "Ajeet Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India."}], "LastName": "Hazra", "ForeName": "Banasri", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Amiri S., Dastghaib S., Ahmadi M., Mehrbod P., Khadem F., Behrouj H., et al. (2020). Betulin and its derivatives as novel compounds with different pharmacological effects. Biotechnol. Adv. 38, 107409\u2013107439. 10.1016/j.biotechadv.2019.06.008", "ArticleIdList": ["10.1016/j.biotechadv.2019.06.008", "31220568"]}, {"Citation": "Anand K., Ziebuhr J., Wadhwani P., Hilgenfeld R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300, 1763\u20131767. 10.1126/science.1085658", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Bachmetov L., Gal-Tanamy M., Shapira A., Vorobeychik M., Giterman-Galam T., Sathiyamoorthy P., et al. (2012). Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J. Viral Hepat. 19, e81\u2013e88. 10.1111/j.1365-2893.2011.01507.x", "ArticleIdList": ["10.1111/j.1365-2893.2011.01507.x", "22239530"]}, {"Citation": "Bae Y., Jae H., Hoon J., Min Y., Park J., Kim D., et al. (2010). Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL pro inhibition. Bioorg. Med. Chem. 18, 7940\u20137947. 10.1016/j.bmc.2010.09.035", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Bafna K., Krug R. M., Montelione G. (2020). Structural similarity of SARS-CoV2 Mpro and HCV NS3/4A proteases suggests new approaches for identifying existing drugs useful as COVID-19 therapeutics. ChemRxiv 2020, 1\u201338. 10.26434/chemrxiv.12153615.v1", "ArticleIdList": ["10.26434/chemrxiv.12153615.v1"]}, {"Citation": "Bahramsoltani R., Rahimi R. (2020). An evaluation of traditional Persian medicine for the management of SARS-CoV-2. Front. Pharmacol. 11, 1\u201329. 10.3389/fphar.2020.571434", "ArticleIdList": ["10.3389/fphar.2020.571434", "PMC7724033", "33324206"]}, {"Citation": "Bailly C., Vergoten G. (2020). Glycyrrhizin: an alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol. Ther. 214, 107618\u2013107714. 10.1016/j.pharmthera.2020.107618", "ArticleIdList": ["10.1016/j.pharmthera.2020.107618", "PMC7311916", "32592716"]}, {"Citation": "Baltina L. A., Zarubaev V. V., Baltina L. A., Orshanskaya I. A., Fairushina A. I., Kiselev O. I., et al. (2015). Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors. Bioorg. Med. Chem. Lett. 25, 1742\u20131746. 10.1016/j.bmcl.2015.02.074", "ArticleIdList": ["10.1016/j.bmcl.2015.02.074", "PMC7127794", "25801933"]}, {"Citation": "Bedford J., Enria D., Giesecke J., Heymann D. L., Ihekweazu C., Kobinger G., et al. (2020). COVID-19: towards controlling of a pandemic. The Lancet 395, 1015\u20131018. 10.1016/S0140-6736(20)30673-5", "ArticleIdList": ["10.1016/S0140-6736(20)30673-5", "PMC7270596", "32197103"]}, {"Citation": "Bianchi M., Benvenuto D., Giovanetti M., Angeletti S., Ciccozzi M., Pascarella S. (2020). Sars-CoV-2 envelope and membrane proteins: structural differences linked to virus characteristics? Biomed. Res. Int. 2020, 1\u20136. 10.1155/2020/4389089", "ArticleIdList": ["10.1155/2020/4389089", "PMC7261327", "32596311"]}, {"Citation": "Bildziukevich U., \u00d6zdemir Z., Wimmer Z. (2019). Recent achievements in medicinal and supramolecular chemistry of betulinic acid and its derivatives. Molecules 24, 3546\u20133620. 10.3390/molecules24193546", "ArticleIdList": ["10.3390/molecules24193546", "PMC6803882", "31574991"]}, {"Citation": "Boskabady M. H., Shahabi M. (1997). Bronchodilatory and anticholinergic effects of Nigella sativa on isolated Guinea pig tracheal chains. Iranj. Med. Sci. 22, 127\u2013133."}, {"Citation": "Burki T. (2020). Outbreak of coronavirus disease 2019. Lancet Infect. Dis. 20, 292\u2013293. 10.1016/S1473-3099(20)30076-1", "ArticleIdList": ["10.1016/S1473-3099(20)30076-1", "PMC7128260", "32078809"]}, {"Citation": "Chen C.-J., Michaelis M., Hsu H.-K., Tsai C.-C., Yang K. D., Wu Y.-C., et al. (2008). Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J. Ethnopharmacol. 120, 108\u2013111. 10.1016/j.jep.2008.07.048", "ArticleIdList": ["10.1016/j.jep.2008.07.048", "PMC7127248", "18762235"]}, {"Citation": "Chen C.-N., Lin C. P. C., Huang K.-K., Chen W.-C., Hsieh H.-P., Liang P.-H., et al. (2005). Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3\u2032-digallate (TF3). Evidence-Based Complement. Altern. Med. 2, 209\u2013215. 10.1093/ecam/neh081", "ArticleIdList": ["10.1093/ecam/neh081", "PMC1142193", "15937562"]}, {"Citation": "Chen Y. W., Yiu C.-P. B., Wong K.-Y. (2020). Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Res. 9, 129\u2013218. 10.12688/f1000research.22457.1", "ArticleIdList": ["10.12688/f1000research.22457.1", "PMC7062204", "32194944"]}, {"Citation": "Chiow K. H., Phoon M. C., Putti T., Tan B. K. H., Chow V. T. (2016). Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac. J. Trop. Med. 9, 1\u20137. 10.1016/j.apjtm.2015.12.002", "ArticleIdList": ["10.1016/j.apjtm.2015.12.002", "PMC7104935", "26851778"]}, {"Citation": "Choudhary S., Malik Y. S., Tomar S. (2020). Identification of SARS-CoV-2 cell entry inhibitors by drug repurposing using in silico structure-based virtual screening approach. Front. Immunol. 11, 1\u201314. 10.3389/fimmu.2020.01664", "ArticleIdList": ["10.3389/fimmu.2020.01664", "PMC7365927", "32754161"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H. (2003). Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet 361, 2045\u20132046. 10.1016/S0140-6736(03)13615-X", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "PMC7112442", "12814717"]}, {"Citation": "Ebeling S., Naumann K., Pollok S., Wardecki T., Vidal-y-Sy S., Nascimento J. M., et al. (2014). From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract. PLoS One 9, e86147. 10.1371/journal.pone.0086147", "ArticleIdList": ["10.1371/journal.pone.0086147", "PMC3899119", "24465925"]}, {"Citation": "Efferth S., Sauter D., Wang K., Zhang R., Sun B., Karioti A., et al. (2014). Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta Med. 80, 177\u2013182. 10.1055/s-0033-1360277", "ArticleIdList": ["10.1055/s-0033-1360277", "PMC7171712", "24458263"]}, {"Citation": "Enmozhi S. K., Raja K., Sebastine I., Joseph J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J. Biomol. Struct. Dyn. 2020, 1\u20137. 10.1080/07391102.2020.1760136", "ArticleIdList": ["10.1080/07391102.2020.1760136", "PMC7212536", "32329419"]}, {"Citation": "Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., et al. (2008). Antiviral effects ofGlycyrrhiza species. Phytother. Res. 22, 141\u2013148. 10.1002/ptr.2295", "ArticleIdList": ["10.1002/ptr.2295", "PMC7167979", "17886224"]}, {"Citation": "Fujioka T., Kashiwada Y., Kilkuskie R. E., Cosentino L. M., Ballas L. M., Jiang J. B., et al. (1994). Anti-aids agents, 11. betulinic acid and platanic acid as anti-HIV principles from syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod. 57, 243\u2013247. 10.1021/np50104a008", "ArticleIdList": ["10.1021/np50104a008", "8176401"]}, {"Citation": "Ganta K. K., Mandal A., Debnath S., Hazra B., Chaubey B. (2017). Anti-HCV activity from semi-purified methanolic root extracts ofValeriana wallichii. Phytother. Res. 31, 433\u2013440. 10.1002/ptr.5765", "ArticleIdList": ["10.1002/ptr.5765", "28078810"]}, {"Citation": "Gilani A. H., Khan A.-u., Raoof M., Ghayur M. N., Siddiqui B. S., Vohra W., et al. (2008). Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundam. Clin. Pharmacol. 22, 87\u201399. 10.1111/j.1472-8206.2007.00561.x", "ArticleIdList": ["10.1111/j.1472-8206.2007.00561.x", "18251725"]}, {"Citation": "Gilani S. A., Kikuchi A., Shinwari Z. K., Khattak Z. I., Watanabe K. N. (2007). Phytochemical, pharmacological and ethnobotanical studies ofRhazya stricta Decne. Phytother. Res. 21, 301\u2013307. 10.1002/ptr.2064", "ArticleIdList": ["10.1002/ptr.2064", "17186492"]}, {"Citation": "\nGolodetz K. S. (2020). 3CL protease inhibitor NLC-001 added to COVID-19-focused joint venture between Todos medical and NLC pharma. Available at: https://www.globenewswire.com/news-release/2020/09/17/2095292/0/en/3CL-Protease-Inhibitor-NLC-001-Added-to-COVID-19-focused-Joint-Venture-Between-Todos-Medical-and-NLC-Pharma.html (Accessed September 17, 2020). "}, {"Citation": "Gordon D. E., Jang G. M., Bouhaddou M., Xu J., Obernier K., White K. M., et al. (2020). A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468. 10.1038/s41586-020-2286-9", "ArticleIdList": ["10.1038/s41586-020-2286-9", "PMC7431030", "32353859"]}, {"Citation": "Govindappa M., Anil Kumar N. V., Gustavo S. (2011). Crotalaria pallida extracts as a putative HIV-protease inhibitors. J. Res. Biol. 1, 285\u2013291."}, {"Citation": "Gyebi G. A., Ogunro O. B., Adegunloye A. P., Ogunyemi O. M., Afolabi S. O., Gyebi G. A., et al. (2020). Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants. J. Biomol. Struct. Dyn. 2020, 1\u201313. 10.1080/07391102.2020.1764868", "ArticleIdList": ["10.1080/07391102.2020.1764868", "PMC7256353", "32367767"]}, {"Citation": "Hamburger M. (2002). Isatis tinctoria\u2014from the rediscovery of an ancient medicinal plant towards a novel anti-inflammatory phytopharmaceutical. Phytochemistry Rev. 1, 333\u2013344. 10.1023/A:1026095608691", "ArticleIdList": ["10.1023/A:1026095608691"]}, {"Citation": "Haqqi T. M., Anthony D. D., Gupta S., Ahmad N., Lee M. S., Kumar G. K., et al. (1999). Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc. Natl. Acad. Sci. 96, 4524\u20134529. 10.1073/pnas.96.8.4524", "ArticleIdList": ["10.1073/pnas.96.8.4524", "PMC16365", "10200295"]}, {"Citation": "He J., Qi W.-B., Wang L., Tian J., Jiao P.-R., Liu G.-Q., et al. (2013). Amaryllidaceae alkaloids inhibit nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1. Influenza Other Respi. Viruses. 7, 922\u2013931. 10.1111/irv.12035", "ArticleIdList": ["10.1111/irv.12035", "PMC4634243", "23136954"]}, {"Citation": "Higdon J. V., Frei B. (2003). Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 43, 89\u2013143. 10.1080/10408690390826464", "ArticleIdList": ["10.1080/10408690390826464", "12587987"]}, {"Citation": "Hinay A. A. H., Sarol L. D. C. (2014). Screening of Mentha cordifolia O piz (Yerba Buena) buffer crude extract for aspartyl protease pepsin inhibitory activity. Int. J. Res. Pharmacol. and Pharmacotherapeutics 3, 28\u201339."}, {"Citation": "Hirano T., Murakami M. (2020). COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52, 731\u2013733. 10.1016/j.immuni.2020.04.003", "ArticleIdList": ["10.1016/j.immuni.2020.04.003", "PMC7175868", "32325025"]}, {"Citation": "Hoever G., Baltina L., Michaelis M., Kondratenko R., Baltina L., Tolstikov G. A., et al. (2005). Antiviral activity of glycyrrhizic acid derivatives against SARS\u2212Coronavirus. J. Med. Chem. 48, 1256\u20131259. 10.1021/jm0493008", "ArticleIdList": ["10.1021/jm0493008", "15715493"]}, {"Citation": "Hussein G., Miyashiro H., Nakamura N., Hattori M., Kakiuchi N., Shimotohno K. (2000). Inhibitory effects of sudanese medicinal plant extracts on hepatitis C virus (HCV) protease. Phytother. Res. 14, 510\u2013516. 10.1002/1099-1573(200011)14:7<510::AID-PTR646>3.0.CO;2-B", "ArticleIdList": ["10.1002/1099-1573(200011)14:7<510::AID-PTR646>3.0.CO;2-B", "11054840"]}, {"Citation": "Islam M. T., Sarkar C., El\u2010Kersh D. M., Jamaddar S., Uddin S. J., Shilpi J. A., et al. (2020). Natural products and their derivatives against coronavirus: a review of the non\u2010clinical and pre\u2010clinical data. Phytotherapy Res. 34, 2471\u20132492. 10.1002/ptr.6700", "ArticleIdList": ["10.1002/ptr.6700", "32248575"]}, {"Citation": "J\u00e4ger S., Laszczyk M., Scheffler A. (2008). A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex). Molecules 13, 3224\u20133235. 10.3390/molecules13123224", "ArticleIdList": ["10.3390/molecules13123224", "PMC6245357", "19104487"]}, {"Citation": "Jiang Z., Gao W., Huang L. (2019). Tanshinones, critical pharmacological components in salvia miltiorrhiza. Front. Pharmacol. 10, 1\u201314. 10.3389/fphar.2019.00202", "ArticleIdList": ["10.3389/fphar.2019.00202", "PMC6426754", "30923500"]}, {"Citation": "Jo S., Kim S., Shin D. H., Kim M.-S., Kim M. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzyme Inhib. Med. Chem. 35, 145\u2013151. 10.1080/14756366.2019.1690480", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Kapoor M., Jasani N., Acharya N., Acharya S., Kumar V. (2011). Phytopharmacological evaluation and anti-asthmatic activity of Ficus religiosa leaves. Asian Pac. J. Trop. Med. 4, 642\u2013644. 10.1016/S1995-7645(11)60163-6", "ArticleIdList": ["10.1016/S1995-7645(11)60163-6", "21914543"]}, {"Citation": "Kavanagh K. T., Hafer L. J., Kim D. W., Mann K. K., Sherr D. H., Rogers A. E., et al. (2001). Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell. Biochem. 82, 387\u2013398. 10.1002/jcb.1164", "ArticleIdList": ["10.1002/jcb.1164", "11500915"]}, {"Citation": "Khaerunnisa S., Kurniawan H., Awaluddin R., Suhartati S., Soetjipto S. (2020). Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints 2020, 1\u201314. 10.20944/preprints202003.0226.v1", "ArticleIdList": ["10.20944/preprints202003.0226.v1"]}, {"Citation": "Khailany R. A., Safdar M., Ozaslan M. (2020). Genomic characterization of a novel SARS-CoV-2. Gene Rep. 19, 100682\u2013100686. 10.1016/j.genrep.2020.100682", "ArticleIdList": ["10.1016/j.genrep.2020.100682", "PMC7161481", "32300673"]}, {"Citation": "Khushboo P., Jadhav V., Kadam V., Sathe N. (2010). Psoralea corylifolia Linn.-\u201cKushtanashini\u201d. Phcog Rev. 4, 69\u201376. 10.4103/0973-7847.65331", "ArticleIdList": ["10.4103/0973-7847.65331", "PMC3249905", "22228944"]}, {"Citation": "Kil Y.-S., Pham S. T., Seo E. K., Jafari M. (2017). Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activities. Arch. Pharm. Res. 40, 655\u2013675. 10.1007/s12272-017-0892-3", "ArticleIdList": ["10.1007/s12272-017-0892-3", "PMC7090720", "28439780"]}, {"Citation": "Kim D. W., Seo K. H., Curtis-Long M. J., Oh K. Y., Oh J.-W., Cho J. K., et al. (2014). Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J. Enzyme Inhib. Med. Chem. 29, 59\u201363. 10.3109/14756366.2012.753591", "ArticleIdList": ["10.3109/14756366.2012.753591", "23323951"]}, {"Citation": "Kim J.-M., Chung Y.-S., Jo H. J., Lee N.-J., Kim M. S., Woo S. H., et al. (2020). Identification of coronavirus isolated from a patient in Korea with covid-19. Osong Public Health Res. Perspect. 11, 3\u20137. 10.24171/j.phrp.2020.11.1.02", "ArticleIdList": ["10.24171/j.phrp.2020.11.1.02", "PMC7045880", "32149036"]}, {"Citation": "Kim J. Y., Kim Y. I., Park S. J., Kim I. K., Choi Y. K., Kim S.-H. (2018). Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein. Int. J. Antimicrob. Agents 52, 730\u2013732. 10.1016/j.ijantimicag.2018.05.003", "ArticleIdList": ["10.1016/j.ijantimicag.2018.05.003", "PMC7125825", "29772395"]}, {"Citation": "Kimura Y., Baba K. (2003). Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: isolation of an active substance, xanthoangelol. Int. J. Cancer 106, 429\u2013437. 10.1002/ijc.11256", "ArticleIdList": ["10.1002/ijc.11256", "12845685"]}, {"Citation": "Ko H. J., Kwon O. S., Jin J. H., Son K. H., Kim H. P. (2013). Inhibition of experimental systemic inflammation (septic inflammation) and chronic bronchitis by new phytoformula BL containing broussonetia papyrifera and lonicera japonica. Biomolecules Ther. 21, 66\u201371. 10.4062/biomolther.2012.081", "ArticleIdList": ["10.4062/biomolther.2012.081", "PMC3762297", "24009861"]}, {"Citation": "Kouokam J., Lasnik A., Palmer K. (2016). Studies in a murine model confirm the safety of griffithsin and advocate its further development as a microbicide targeting HIV-1 and other enveloped viruses. Viruses 8, 311. 10.3390/v8110311", "ArticleIdList": ["10.3390/v8110311", "PMC5127025", "27869695"]}, {"Citation": "Krichel B., Falke S., Hilgenfeld R., Redecke L., Uetrecht C. (2020). Processing of the SARS-CoV pp1a/ab nsp7-10 region. Biochem. J. 477, 1009\u20131019. 10.1042/BCJ20200029", "ArticleIdList": ["10.1042/BCJ20200029", "PMC7078746", "32083638"]}, {"Citation": "Kurt Yilmaz N., Swanstrom R., Schiffer C. A. (2016). Improving viral protease inhibitors to counter drug resistance. Trends Microbiol. 24, 547\u2013557. 10.1016/j.tim.2016.03.010", "ArticleIdList": ["10.1016/j.tim.2016.03.010", "PMC4912444", "27090931"]}, {"Citation": "Lee P.-I., Hsueh P.-R. (2020). Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J. Microbiol. Immunol. Infect. 53, 365\u2013367. 10.1016/j.jmii.2020.02.001", "ArticleIdList": ["10.1016/j.jmii.2020.02.001", "PMC7102579", "32035811"]}, {"Citation": "Lee S., Yoon K. D., Lee M., Cho Y., Choi G., Jang H., et al. (2016). Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase. Br. J. Pharmacol. 173, 191\u2013211. 10.1111/bph.13358", "ArticleIdList": ["10.1111/bph.13358", "PMC4813382", "26445091"]}, {"Citation": "Li J.-y., Cao H.-y., Liu P., Cheng G.-h., Sun M.-y. (2014a). Glycyrrhizic acid in the treatment of liver diseases: literature review. Biomed. Res. Int. 2014, 1\u201315. 10.1155/2014/872139", "ArticleIdList": ["10.1155/2014/872139", "PMC4052927", "24963489"]}, {"Citation": "Li M., Li Q., Zhang C., Zhang N., Cui Z., Huang L., et al. (2013). An ethnopharmacological investigation of medicinal Salvia plants (Lamiaceae) in China. Acta Pharm. Sin. B. 3, 273\u2013280. 10.1016/j.apsb.2013.06.001", "ArticleIdList": ["10.1016/j.apsb.2013.06.001"]}, {"Citation": "Li M., Shi A., Pang H., Xue W., Li Y., Cao G., et al. (2014b). Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. J. Ethnopharmacol. 156, 210\u2013215. 10.1016/j.jep.2014.08.031", "ArticleIdList": ["10.1016/j.jep.2014.08.031", "25219601"]}, {"Citation": "Li S., Chen C., Zhang H., Guo H., Wang H., Wang L., et al. (2005). Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 67, 18\u201323. 10.1016/j.antiviral.2005.02.007", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Lin C.-W., Tsai F.-J., Tsai C.-H., Lai C.-C., Wan L., Ho T.-Y., et al. (2005). Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 68, 36\u201342. 10.1016/j.antiviral.2005.07.002", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Lin S.-C., Ho C.-T., Chuo W.-H., Li S., Wang T. T., Lin C.-C. (2017). Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect. Dis. 17, 1\u201310. 10.1186/s12879-017-2253-8", "ArticleIdList": ["10.1186/s12879-017-2253-8", "PMC5307780", "28193191"]}, {"Citation": "Liu H., Ye F., Sun Q., Liang H., Li C., Lu R., et al. (2020). Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro . bioRxiv 2020, 1\u201318. 10.1101/2020.04.10.035824", "ArticleIdList": ["10.1101/2020.04.10.035824", "PMC7850424", "33491508"]}, {"Citation": "Liu J., Yang Y., Xu Y., Ma C., Qin C., Zhang L. (2011). Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol. J. 8, 483\u2013489. 10.1186/1743-422X-8-483", "ArticleIdList": ["10.1186/1743-422X-8-483", "PMC3212826", "22029605"]}, {"Citation": "Lu H. (2020). Drug treatment options for the 2019-new coronavirus (2019-nCoV). Bst 14, 69\u201371. 10.5582/BST.2020.01020", "ArticleIdList": ["10.5582/BST.2020.01020", "31996494"]}, {"Citation": "Luo P., Liu D., Li J. (2020). Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19. Int. J. Antimicrob. Agents 55, 105995\u2013106004. 10.1016/j.ijantimicag.2020.105995", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105995", "PMC7180159", "32335281"]}, {"Citation": "Luo W., Su X., Gong S., Qin Y., Liu W., Li J., et al. (2009). Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci. Trends 3, 124\u2013126.", "ArticleIdList": ["20103835"]}, {"Citation": "\nMacchiagodena M., Pagliai M., Procacci P. (2020). Inhibition of the main protease 3CLPro of the coronavirus disease 19 via structure-based ligand design and molecular modeling. Available at: https://arxiv.org/pdf/2002.09937.pdf (Accessed March 2, 2020). ", "ArticleIdList": ["PMC7165110", "32313296"]}, {"Citation": "Mail P. R., Patil C. R., Rahila S., Karigar A. (2011). Studies on antiasthmatic activity of aqueous extract of roots of Mimosa pudica linn. Int. Res. J. Pharm. 2, 104\u2013110."}, {"Citation": "Matsuse I. T., Lim Y. A., Hattori M., Correa M., Gupta M. P. (1998). A search for anti-viral properties in Panamanian medicinal plants. J. Ethnopharmacol. 64, 15\u201322. 10.1016/S0378-8741(98)00099-3", "ArticleIdList": ["10.1016/S0378-8741(98)00099-3", "10075118"]}, {"Citation": "Mori T., O\u2019Keefe B. R., Sowder R. C., Bringans S., Gardella R., Berg S., et al. (2005). Isolation and characterization of Griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem. 280, 9345\u20139353. 10.1074/jbc.M411122200", "ArticleIdList": ["10.1074/jbc.M411122200", "15613479"]}, {"Citation": "Moyers S. B., Kumar N. B. (2004). Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr. Rev. 62, 204\u2013211. 10.1111/j.1753-4887.2004.tb00041.x", "ArticleIdList": ["10.1111/j.1753-4887.2004.tb00041.x", "15212320"]}, {"Citation": "Muhseen Z. T., Hameed A. R., Al-Hasani H. M. H., Tahir ul Qamar M., Li G. (2020). Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: integrated computational approach. J. Mol. Liquids 320, 114493\u2013114510. 10.1016/j.molliq.2020.114493", "ArticleIdList": ["10.1016/j.molliq.2020.114493", "PMC7538380", "33041407"]}, {"Citation": "Nair J. J., Van Staden J. (2014). Cytotoxicity studies of lycorine alkaloids of the amaryllidaceae. Nat. Product Commun. 9, 1193-210. 10.1177/1934578x1400900834", "ArticleIdList": ["10.1177/1934578x1400900834", "25233606"]}, {"Citation": "Navid M., Laszczyk-Lauer M. N., Reichling J., Schnitzler P. (2014). Pentacyclic triterpenes in birch bark extract inhibit early step of herpes simplex virus type 1 replication. Phytomedicine 21, 1273\u20131280. 10.1016/j.phymed.2014.06.007", "ArticleIdList": ["10.1016/j.phymed.2014.06.007", "25172789"]}, {"Citation": "Otake T., Mori H., Morimoto M., Ueba N., Sutardjo S., Kusumoto I. T., et al. (1995). Screening of Indonesian plant extracts for anti-human immunodeficiency virus-type 1 (HIV-1) activity. Phytother. Res. 9, 6\u201310. 10.1002/ptr.2650090103", "ArticleIdList": ["10.1002/ptr.2650090103"]}, {"Citation": "Owis A. I., El-Hawary M. S., El Amir D., Aly O. M., Abdelmohsen U. R., Kamel M. S. (2020). Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease. RSC Adv. 10, 19570\u201319575. 10.1039/d0ra03582c", "ArticleIdList": ["10.1039/d0ra03582c", "PMC9054211", "35515460"]}, {"Citation": "O\u2019Keefe B. R., Giomarelli B., Barnard D. L., Shenoy S. R., Chan P. K., McMahon J. B., et al. (2010). Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J. Virol. 84, 2511\u20132521. 10.1128/jvi.02322-09", "ArticleIdList": ["10.1128/jvi.02322-09", "PMC2820936", "20032190"]}, {"Citation": "O\u2019Keefe B. R., Vojdani F., Buffa V., Shattock R. J., Montefiori D. C., Bakke J., et al. (2009). Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc. Natl. Acad. Sci. USA 106, 6099\u20136104. 10.1073/pnas.0901506106", "ArticleIdList": ["10.1073/pnas.0901506106", "PMC2662964", "19332801"]}, {"Citation": "Panda S. K., Padhi L., Leyssen P., Liu M., Neyts J., Luyten W. (2017). Antimicrobial, anthelmintic, and antiviral activity of plants traditionally used for treating infectious disease in the Similipal Biosphere Reserve, Odisha, India. Front. Pharmacol. 8, 1\u201315. 10.3389/fphar.2017.00658", "ArticleIdList": ["10.3389/fphar.2017.00658", "PMC5660100", "29109684"]}, {"Citation": "Park J.-Y., Kim J. H., Kim Y. M., Jeong H. J., Kim D. W., Park K. H., et al. (2012). Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg. Med. Chem. 20, 5928\u20135935. 10.1016/j.bmc.2012.07.038", "ArticleIdList": ["10.1016/j.bmc.2012.07.038", "PMC7127169", "22884354"]}, {"Citation": "Park J.-Y., Ko J.-A., Kim D. W., Kim Y. M., Kwon H.-J., Jeong H. J., et al. (2016). Chalcones isolated fromAngelica keiskeiinhibit cysteine proteases of SARS-CoV. J. Enzyme Inhib. Med. Chem. 31, 23\u201330. 10.3109/14756366.2014.1003215", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Park J. C., Hur J. M., Park J. G., Hatano T., Yoshida T., Miyashiro H., et al. (2002). Inhibitory effects of Korean medicinal plants and camelliatannin H from Camellia japonica on human immunodeficiency virus type 1 protease. Phytother. Res. 16, 422\u2013426. 10.1002/ptr.919", "ArticleIdList": ["10.1002/ptr.919", "12203260"]}, {"Citation": "Patel K. G., Detroja J. R., Shah T. A., Patel K. V., Gandhi T. R. (2011). Evaluation of the effect of Onosma bracteatum, wall (Boraginaceae) using experimental allergic and inflammatory models. Glob. J. Pharmacol. 5, 40\u201349."}, {"Citation": "Pavlova N. I., Savinova O. V., Nikolaeva S. N., Boreko E. I., Flekhter O. B. (2003). Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses. Fitoterapia 74, 489\u2013492. 10.1016/S0367-326X(03)00123-0", "ArticleIdList": ["10.1016/S0367-326X(03)00123-0", "12837369"]}, {"Citation": "Pillaiyar T., Manickam M., Namasivayam V., Hayashi Y., Jung S.-H. (2016). An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J. Med. Chem. 59, 6595\u20136628. 10.1021/acs.jmedchem.5b01461", "ArticleIdList": ["10.1021/acs.jmedchem.5b01461", "PMC7075650", "26878082"]}, {"Citation": "Rastogi S., Pandey M. M., Kumar Singh Rawat A. (2015). Medicinal plants of the genus Betula-Traditional uses and a phytochemical-pharmacological review. J. Ethnopharmacol. 159, 62\u201383. 10.1016/j.jep.2014.11.010", "ArticleIdList": ["10.1016/j.jep.2014.11.010", "PMC7126499", "25449458"]}, {"Citation": "Ravikumar Y. S., Ray U., Nandhitha M., Perween A., Raja Naika H., Khanna N., et al. (2011). Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus. Res. 158, 89\u201397. 10.1016/j.virusres.2011.03.014", "ArticleIdList": ["10.1016/j.virusres.2011.03.014", "21440018"]}, {"Citation": "Roccaro A., Blanco A. R., Giuliano F., Rusciano D., Enea V. (2004). Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob. Agents Chemother. 48, 1968\u20131973. 10.1128/AAC.48.6.1968-1973.2004", "ArticleIdList": ["10.1128/AAC.48.6.1968-1973.2004", "PMC415601", "15155186"]}, {"Citation": "Rodr\u00edguez-Morales A. J., MacGregor K., Kanagarajah S., Patel D., Schlagenhauf P. (2020). Going global\u2014travel and the 2019 novel coronavirus. Trav. Med. Infect. Dis. 33, 101578\u2013101585. 10.1016/j.tmaid.2020.101578", "ArticleIdList": ["10.1016/j.tmaid.2020.101578", "PMC7128681", "32044389"]}, {"Citation": "Rota P. A., Rota P. A., Oberste M. S., Monroe S. S., Nix W. A., Campagnoli R., et al. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394\u20131399. 10.1126/science.1085952", "ArticleIdList": ["10.1126/science.1085952", "12730500"]}, {"Citation": "Sah P., Agarwal D., Garg S. (2006). Isolation and identification of furocoumarins from the seeds ofPsoralea corylifolialinn. Indian J. Pharm. Sci. 68, 768\u2013771. 10.4103/0250-474X.31012", "ArticleIdList": ["10.4103/0250-474X.31012"]}, {"Citation": "Savithramma N., Sulochana C., Rao K. N. (2007). Ethnobotanical survey of plants used to treat asthma in Andhra Pradesh, India. J. Ethnopharmacol. 113, 54\u201361. 10.1016/j.jep.2007.04.004", "ArticleIdList": ["10.1016/j.jep.2007.04.004", "17606346"]}, {"Citation": "Shen M.-x., Ma N., Li M.-k., Liu Y.-y., Chen T., Wei F., et al. (2019). Antiviral properties of R. Tanguticum nanoparticles on herpes simplex virus type I in Vitro and in Vivo . Front. Pharmacol. 10, 1\u201313. 10.3389/fphar.2019.00959", "ArticleIdList": ["10.3389/fphar.2019.00959", "PMC6737004", "31555137"]}, {"Citation": "Shereen M. A., Khan S., Kazmi A., Bashir N., Siddique R. (2020). COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 24, 91\u201398. 10.1016/j.jare.2020.03.005", "ArticleIdList": ["10.1016/j.jare.2020.03.005", "PMC7113610", "32257431"]}, {"Citation": "Shi J., Song J. (2006). The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. FEBS J. 273, 1035\u20131045. 10.1111/j.1742-4658.2006.05130.x", "ArticleIdList": ["10.1111/j.1742-4658.2006.05130.x", "PMC7164011", "16478476"]}, {"Citation": "Shibata S. (2000). A drug over the millennia : pharmacognosy, chemistry, and Pharmacology of licorice. Yakugaku Zasshi 120, 849\u2013862. 10.1248/yakushi1947.120.10_849", "ArticleIdList": ["10.1248/yakushi1947.120.10_849", "11082698"]}, {"Citation": "Singh K. P., Upadhyay R., Kumar A. (2010). Screening of adhatoda vasica needs as a putative HIV-protease inhibitor. J. Phytol. 2, 78\u201382."}, {"Citation": "Speranza J., Miceli N., Taviano M. F., Ragusa S., Kwiecie\u0144 I., Szopa A., et al. (2020). Isatis tinctoria L. (woad): a review of its botany, ethnobotanical uses, phytochemistry, biological activities, and biotechnological studies, Plants 9, 298\u2013340. 10.3390/plants9030298", "ArticleIdList": ["10.3390/plants9030298", "PMC7154893", "32121532"]}, {"Citation": "Sueoka N., Suganuma M., Sueoka E., Okabe S., Matsuyama S., Imai K., et al. (2001). A new function of green tea: prevention of lifestyle-related diseases. Ann. New York Acad. Sci. 928, 274\u2013280. 10.1111/j.1749-6632.2001.tb05656.x", "ArticleIdList": ["10.1111/j.1749-6632.2001.tb05656.x", "11795518"]}, {"Citation": "Tahir ul Qamar M., Alqahtani S. M., Alamri M. A., Chen L.-L. (2020). Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal., 10, 313\u2013319. 10.1016/j.jpha.2020.03.009", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "Thanh T. T., Nguyen H. J., Kang H. K., Nguyen V. D., Kim Y. M., Kim D. W., et al. (2012). Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol. Lett. 34, 831\u2013838. 10.1007/s10529-011-0845-8", "ArticleIdList": ["10.1007/s10529-011-0845-8", "PMC7087583", "22350287"]}, {"Citation": "Thayil, Seema M., Thyagarajan S. P. (2016). Pa-9: a flavonoid extracted from plectranthus amboinicus inhibits HIV-1 protease. Int. J. Pharmacogn. Phytochem. Res. 8, 1020\u20131024."}, {"Citation": "Wan M., Bloor S., Foo L.-Y., Loh B.-N. (1996). Screening of New Zealand plant extracts for inhibitory activity against HIV-1 protease. Phytother. Res. 10, 589\u2013595. 10.1002/(sici)1099-1573(199611)10:7<589::aid-ptr910>3.0.co;2-#", "ArticleIdList": ["10.1002/(sici)1099-1573(199611)10:7<589::aid-ptr910>3.0.co;2-#"]}, {"Citation": "Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., et al. (2020). Structural basis for RNA replication by the SARS-CoV-2 polymerase. Cell 182, 417\u2013428. 10.1016/j.cell.2020.05.034", "ArticleIdList": ["10.1016/j.cell.2020.05.034", "PMC7242921", "32526208"]}, {"Citation": "Weber J. M., Ruzindana-Umunyana A., Imbeault L., Sircar S. (2003). Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res. 58, 167\u2013173. 10.1016/S0166-3542(02)00212-7", "ArticleIdList": ["10.1016/S0166-3542(02)00212-7", "12742577"]}, {"Citation": "Weinreb O., Mandel S., Amit T., Youdim M. B. H. (2004). Neurological mechanisms of green tea polyphenols in Alzheimer\u2019s and Parkinson\u2019s diseases. J. Nutr. Biochem. 15, 506\u2013516. 10.1016/j.jnutbio.2004.05.002", "ArticleIdList": ["10.1016/j.jnutbio.2004.05.002", "15350981"]}, {"Citation": "Wen C.-C., Kuo Y.-H., Jan J.-T., Liang P.-H., Wang S.-Y., Liu H.-G., et al. (2007). Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 50, 4087\u20134095. 10.1021/jm070295s", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "WHO (2004). Clinical trials on treatment using a combination of traditional Chinese medicine and Western medicine. Geneva, Switzerland: WHO."}, {"Citation": "WHO (2020). WHO coronavirus disease (COVID-19) dashboard. Geneva, Switzerland: WHO."}, {"Citation": "Wu C.-Y., Jan J.-T., Ma S.-H., Kuo C.-J., Juan H.-F., Cheng Y.-S. E., et al. (2004). Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. 101, 10012\u201310017. 10.1073/pnas.0403596101", "ArticleIdList": ["10.1073/pnas.0403596101", "PMC454157", "15226499"]}, {"Citation": "Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., et al. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 10, 766\u2013788. 10.1016/j.apsb.2020.02.008", "ArticleIdList": ["10.1016/j.apsb.2020.02.008", "PMC7102550", "32292689"]}, {"Citation": "Xu H.-X., Zeng F.-Q., Wan M., Sim K.-Y. (1996). Anti-HIV triterpene acids fromGeum japonicum. J. Nat. Prod. 59, 643\u2013645. 10.1021/np960165e", "ArticleIdList": ["10.1021/np960165e", "8759159"]}, {"Citation": "Yamada P., Iijima R., Han J., Shigemori H., Yokota S., Isoda H. (2010). Inhibitory effect of acteoside isolated fromCistanche tubulosaon chemical mediator release and inflammatory cytokine production by RBL-2H3 and KU812 cells. Planta Med. 76, 1512\u20131518. 10.1055/s-0030-1249775", "ArticleIdList": ["10.1055/s-0030-1249775", "20354949"]}, {"Citation": "Yang H., Yang M., Ding Y., Liu Y., Lou Z., Zhou Z., et al. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. 100, 13190\u201313195. 10.1073/pnas.1835675100", "ArticleIdList": ["10.1073/pnas.1835675100", "PMC263746", "14585926"]}, {"Citation": "Yao D., Li H., Gou Y., Zhang H., Vlessidis A. G., Zhou H., et al. (2009). Betulinic acid-mediated inhibitory effect on hepatitis B virus by suppression of manganese superoxide dismutase expression. FEBS J. 276, 2599\u20132614. 10.1111/j.1742-4658.2009.06988.x", "ArticleIdList": ["10.1111/j.1742-4658.2009.06988.x", "19348625"]}, {"Citation": "Yu M.-S., Lee J., Lee J. M., Kim Y., Chin Y.-W., Jee J.-G., et al. (2012). Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 22, 4049\u20134054. 10.1016/j.bmcl.2012.04.081", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., et al. (2020a). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science 368, 409\u2013412. 10.1126/science.abb3405", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Zhang Y.-N., Zhang Q.-Y., Li X.-D., Xiong J., Xiao S.-Q., Wang Z., et al. (2020b). Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture. Emerg. microbes and infect. 9, 1170\u20131173. 10.1080/22221751.2020.1772676", "ArticleIdList": ["10.1080/22221751.2020.1772676", "PMC7448857", "32432977"]}, {"Citation": "Zhang Z.-j., Wu W.-y., Hou J.-j., Zhang L.-l., Li F.-f., Gao L., et al. (2020c). Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC-MSE analysis. J. Integr. Med. 18, 229\u2013241. 10.1016/j.joim.2020.03.004", "ArticleIdList": ["10.1016/j.joim.2020.03.004", "PMC7195604", "32307268"]}, {"Citation": "Zhuang M., Jiang H., Suzuki Y., Li X., Xiao P., Tanaka T., et al. (2009). Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res. 82, 73\u201381. 10.1016/j.antiviral.2009.02.001", "ArticleIdList": ["10.1016/j.antiviral.2009.02.001", "PMC7114128", "19428598"]}, {"Citation": "Zou G., Puig-Basagoiti F., Zhang B., Qing M., Chen L., Pankiewicz K. W., et al. (2009). A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology 384, 242\u2013252. 10.1016/j.virol.2008.11.003", "ArticleIdList": ["10.1016/j.virol.2008.11.003", "PMC5388927", "19062063"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "14"}, {"Year": "2021", "Month": "1", "Day": "19"}, {"Year": "2021", "Month": "3", "Day": "26", "Hour": "6", "Minute": "55"}, {"Year": "2021", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "3", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["33767619", "PMC7985176", "10.3389/fphar.2021.583387", "583387"]}}], "PubmedBookArticle": []}